
Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: A randomized, double-blind, placebo-controlled clinical trial
Keywords: اسکلروز سیستمیک; Systemic sclerosis; Raynaud's Phenomenon; Oxidative stress; N-Acetylcysteine; TreatmentEsclerose sistêmica; Fenômeno de Raynaud; Estresse oxidativo; N-acetilcisteína; Tratamento